Effectiveness of 'Tackle Your Tics', a brief, intensive group-based exposure therapy programme for children with tic disorders: study protocol of a randomised controlled trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
28 06 2022
Historique:
entrez: 29 6 2022
pubmed: 30 6 2022
medline: 2 7 2022
Statut: epublish

Résumé

This paper outlines the study protocol for the Dutch Tackle Your Tics study in youth with tic disorders. Tourette syndrome and chronic tic disorders are prevalent neurodevelopmental disorders, placing considerable burden on youth and their families. Behavioural treatment is the first-line, evidence-based intervention for tic disorders, but tic reduction and availability remain relatively low. Patient associations stress the need for more accessible high-quality treatments, also focusing on improving quality of life. Therefore, the brief, intensive group-based treatment Tackle Your Tics was developed. Tackle Your Tics is a 4-day intensive and comprehensive group-based intervention for children and adolescents (9-17 years) with Tourette syndrome or a chronic tic disorder. The programme encompasses exposure and response prevention treatment and additional supporting components (coping strategies, relaxation exercises and parent support). To study the effectiveness of Tackle Your Tics and identify predictors/moderators at baseline, a single-blinded randomised controlled trial (n=104) is conducted, comparing Tackle Your Tics (n=52) with a waiting list condition lasting 3 months (n=52). Assessments are performed at similar time points for both groups: at baseline, after 4 weeks, and at 3 and 6 months of follow-up, on tic severity, quality of life and other psychosocial variables. Ethics approval has been obtained from the medical ethical committee of the Amsterdam Medical Centre (METC nr NL66340.018.18, v3 June 2020). Findings will be presented on national and international conferences, peer-reviewed scientific journals, patient organisation meetings and public media. Patient representatives are fully integrated as part of the research team. If Tackle Your Tics proves to be effective, it can expand evidence-based treatment possibilities for children and adolescents with tic disorders. Identifying the psychosocial predictors/moderators for the effectiveness of this intervention can provide personalised treatment advice in the future. NL8052.

Identifiants

pubmed: 35768093
pii: bmjopen-2021-058534
doi: 10.1136/bmjopen-2021-058534
pmc: PMC9240895
doi:

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e058534

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: CV and JMTMG developed and published the manual ‘Tics’ and the training app BT-Coach (BT-Tics Foundation), which are both being used in the programme. On behalf of all authors, the corresponding author states that there are no other conflicts of interest.

Références

Behav Res Ther. 2016 May;80:43-50
pubmed: 27037483
Community Ment Health J. 2013 Feb;49(1):110-20
pubmed: 22052430
J Psychosom Res. 2008 Nov;65(5):461-72
pubmed: 18940377
J Pediatr Psychol. 2007 Sep;32(8):950-9
pubmed: 17522110
J Neurol. 2010 Jul;257(7):1055-61
pubmed: 20179960
Eur Child Adolesc Psychiatry. 2022 Mar;31(3):403-423
pubmed: 34313861
Qual Life Res. 2010 Aug;19(6):875-86
pubmed: 20405245
Eur Child Adolesc Psychiatry. 2022 Apr;31(4):637-648
pubmed: 33415472
Eur Child Adolesc Psychiatry. 2016 Feb;25(2):127-39
pubmed: 26316059
Contemp Clin Trials. 2013 Nov;36(2):414-20
pubmed: 24001701
Qual Life Res. 2006 Aug;15(6):1005-21
pubmed: 16900281
J Psychiatr Res. 2014 Mar;50:106-12
pubmed: 24398255
Depress Anxiety. 2003;17(2):73-7
pubmed: 12621595
Behav Res Ther. 2004 May;42(5):501-11
pubmed: 15033497
Neurosci Biobehav Rev. 2013 Jul;37(6):1172-7
pubmed: 23089154
Compr Psychiatry. 2013 Oct;54(7):1023-31
pubmed: 23806708
BMC Health Serv Res. 2013 Jun 15;13:217
pubmed: 23768141
JAMA Neurol. 2018 Sep 1;75(9):1098-1105
pubmed: 29813161
J Dev Behav Pediatr. 2005 Dec;26(6):397-403
pubmed: 16344654
Eur Child Adolesc Psychiatry. 2022 Feb;31(2):275-287
pubmed: 33231786
Behav Ther. 2018 May;49(3):331-343
pubmed: 29704964
Psychiatry Res. 2014 Dec 30;224(3):269-74
pubmed: 25444535
Mov Disord. 2011 Mar;26(4):735-8
pubmed: 21506153
Pediatr Neurol. 2012 Aug;47(2):77-90
pubmed: 22759682
J Am Acad Child Adolesc Psychiatry. 2006 Nov;45(11):1354-1362
pubmed: 17075358
BMJ Open. 2019 Feb 15;9(2):e024685
pubmed: 30772854
J Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):469-478
pubmed: 17420681
Neurology. 2017 Mar 14;88(11):1029-1036
pubmed: 28202705
Behav Neurol. 2013;27(1):95-103
pubmed: 23598902
Eur Child Adolesc Psychiatry. 2021 Mar;30(3):461-473
pubmed: 32436035
Psychiatry Res. 2015 Feb 28;225(3):571-9
pubmed: 25500348
Behav Modif. 2018 Sep;42(5):707-728
pubmed: 28918645
Stat Med. 2016 Aug 30;35(19):3424-48
pubmed: 27059703
J Am Acad Child Adolesc Psychiatry. 2003 Nov;42(11):1370-5
pubmed: 14566175
Compr Psychiatry. 2013 Jul;54(5):462-6
pubmed: 23332555
Fam Process. 1988 Mar;27(1):97-104
pubmed: 3360100
JAMA Psychiatry. 2015 Apr;72(4):325-33
pubmed: 25671412
J Child Psychol Psychiatry. 2017 Nov;58(11):1229-1238
pubmed: 29057522
Eur Child Adolesc Psychiatry. 2012 Jan;21(1):5-13
pubmed: 22038343
Behav Ther. 2010 Sep;41(3):414-22
pubmed: 20569789
Psychol Assess. 2005 Dec;17(4):486-91
pubmed: 16393016
Eur Child Adolesc Psychiatry. 2019 Jan;28(1):57-68
pubmed: 29956034
Behav Res Ther. 2021 May;140:103844
pubmed: 33770556
J Am Acad Child Adolesc Psychiatry. 1989 Jul;28(4):566-73
pubmed: 2768151
Behav Res Ther. 2017 Oct;97:134-145
pubmed: 28772195
Child Care Health Dev. 2009 Jul;35(4):496-504
pubmed: 19638024
Neurosci Biobehav Rev. 2020 Dec;119:21-36
pubmed: 32980398
J Consult Clin Psychol. 2014 Apr;82(2):212-24
pubmed: 24417601

Auteurs

Annet Heijerman-Holtgrefe (A)

Department of Child and Adolescent Psychiatry, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
Levvel, Academic Center for Child and Adolescent Psychiatry and Specialized Youth Care, Amsterdam, The Netherlands.
Dutch Tourette Association, Haarlem, The Netherlands.

Chaim Huyser (C)

Levvel, Academic Center for Child and Adolescent Psychiatry and Specialized Youth Care, Amsterdam, The Netherlands.

Cara Verdellen (C)

PsyQ Nijmegen/Parnassia Group, Nijmegen, The Netherlands.
TicXperts, Heteren, The Netherlands.

Jolande van de Griendt (J)

TicXperts, Heteren, The Netherlands.

Laura Beljaars (L)

Levvel, Academic Center for Child and Adolescent Psychiatry and Specialized Youth Care, Amsterdam, The Netherlands.
Dutch Tourette Association, Haarlem, The Netherlands.
Parnassia Group, The Hague, The Netherlands.

Kees-Jan Kan (KJ)

Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands.

Ramón Lindauer (R)

Department of Child and Adolescent Psychiatry, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
Levvel, Academic Center for Child and Adolescent Psychiatry and Specialized Youth Care, Amsterdam, The Netherlands.

Daniëlle Cath (D)

Department of Specialized Training, GGZ Drenthe, Assen, The Netherlands.
University Medical Center Groningen, Department of Psychiatry, University of Groningen, Groningen, The Netherlands.

Pieter Hoekstra (P)

University Medical Center Groningen, Department of Child and Adolescent Psychiatry, University of Groningen, Groningen, The Netherlands.

Lisbeth Utens (L)

Levvel, Academic Center for Child and Adolescent Psychiatry and Specialized Youth Care, Amsterdam, The Netherlands l.utens@levvel.nl.
Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands.
Department of Child and Adolescent Psychiatry/Psychology, Erasmus MC - Sophia Children's Hospital, Rotterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH